ki:elements

AI-driven speech biomarkers for

motor

function

ki:e SB-M

SB-M by ki:elements

objective, scalable

speech-based motor assessments

QUANTIFY MOTOR SYMPTOMS THROUGH EVERYDAY SPEECH

SB-M

 

SB-M is an AI-driven digital outcome assessment for motor impairments in Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), multiple system atrophy (MSA), and related disorders. It enables sensitive, reliable, and remote-capable monitoring of motor function, enhancing clinical trials from early detection to disease progression tracking. 2 gold standard speech tasks (Sustained phonation and PaTaKa), a reading task, and a monologue task are performed in less than 5 minutes, and 100 features are automatically extracted. 

Intelligibility is a

clinically meaningful

aspect of communication

Affected individuals value and seek to preserve intelligibility, and it can be measured objectively & automatically through conversational speech.

Explore further into the following disease areas we support:

Built for real-world clinical research

OBJECTIVE AND AUTOMATED

Remove subjectivity and variability with consistent, high-quality scoring—anytime, anywhere.

Sensitive to Speech Subsystems

Measure changes in articulation, fluency, and prosody with precision for a deeper view of disease impact.

motor-fluctuation resilient

Accurately track ON/OFF states in individuals with Parkinson’s.

PATIENT-CENTRIC and MEANINGFUL

Quantify what matters with our Intelligibility Score.

Transparent and Trackable

View assessment progress and completion to support consistent longitudinal monitoring.

Effortlessly Integrated

Fit into existing workflows without added burden on sites or patients. Use it out-of-the-box with our Mili System or integrate into third party systems.

Smarter

Algorithms —

Stronger

Evidence

Validation based on global cohorts following approved methodology from the V3 framework of the Digital Medicine Society (DiME)

SB-M reliably differentiates between motor disorder phenotypes (PD, ALS, HD, PSP) and healthy controls, demonstrating clinical validity across diseases, languages, and sites.

High correlation with clinical cognition rating anchors.

Automatic speech analysis combined with machine learning reliably predicts motor state in Parkinson's disease

Thies et al. (2025) | doi: 10.1038/s41531-025-00959-4

An automatic measure for speech intelligibility in dysarthrias-validation across multiple langagues and neurological disorders

Tröger et al. (2024) | doi: 10.3389/fdgth.2024.1440986

Ready to use SB-M in

your

study?